Side effects of Mounjaro: what actually happens and when to act

Why do so many people get nausea on Mounjaro, and does it go away?

Tirzepatide slows how quickly your stomach empties. That's part of how it reduces appetite, but it's also the reason your digestive system needs time to adjust. Nausea is the side effect patients most often mention, the NHS tirzepatide medicines page lists it alongside vomiting, diarrhoea, constipation, indigestion and burping as the most commonly reported effects.

There's a widespread assumption that if you feel sick, something has gone wrong. For most people, that's not what's happening. The starter dose of 2.5mg exists specifically to let your body adjust gradually before any therapeutic increase. Symptoms peak around the first couple of weeks at each dose level, then tend to ease. Eating smaller meals, avoiding greasy food and staying well hydrated are practical measures that help many people get through the settling-in period.

Fatigue, headaches and dizziness also appear on the common-effects list, though they're reported less frequently than the GI effects. Injection-site reactions (redness or mild discomfort where you've administered the pen) are generally short-lived. If you want a more granular breakdown of which effects appear at which dose, our page covering the 5 Mounjaro side effects most commonly reported by patients goes into more detail.

Which Mounjaro side effects need urgent medical attention?

Most people won't experience serious side effects, but it matters to know which symptoms should not be left until your next scheduled review.

Severe, persistent abdominal pain that radiates toward your back (with or without vomiting) is the symptom pattern linked to acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis as an infrequent but serious risk. Stop the injection and go to A&E or call 999 if that pain profile matches what you're feeling. Don't wait to see whether it passes.

Other situations that warrant prompt medical contact: signs of a significant allergic reaction (swelling of the face, throat or tongue; difficulty breathing; severe skin reactions); gallbladder symptoms such as upper-right abdominal pain, fever or jaundice; and signs of dehydration following prolonged vomiting or diarrhoea, dark urine, muscle cramps, confusion. If you have type 2 diabetes alongside Mounjaro treatment, sudden vision changes also need prompt assessment.

For anything lower-grade that isn't resolving, our aftercare team is available seven days a week. You can also explore the topic of low mood reported alongside Mounjaro if that's a concern for you, it's a question our prescribers hear regularly, and there are clear things to look out for.

Are there people for whom the side-effect risk is higher?

Yes. Tirzepatide isn't appropriate for everyone, and part of what the prescribing assessment does is identify where the risk profile shifts.

People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 should not use Mounjaro. A history of pancreatitis or certain gastrointestinal conditions also requires careful prescriber discussion rather than a straightforward green light. Mounjaro is not recommended during pregnancy, while breastfeeding, or for anyone actively trying to conceive. It is not licensed for use under the age of 18.

There is also a practical interaction worth knowing about: if you take an oral contraceptive pill, the MHRA and NHS guidance advise adding a non-oral method of contraception for the first four weeks of Mounjaro treatment and for four weeks after each dose increase. Tirzepatide's effect on gastric emptying can reduce how much of the pill is absorbed. NHS England also notes that people using oral HRT may want to discuss transdermal alternatives with their GP for the same reason. If you're weighing up ways to minimise side effects, contraception is one of the practical details worth getting right before you start.

The prescribing process at nume involves a real clinician reading your full health history, not a form that generates a recommendation automatically. Our FAQs cover the eligibility and safety checks in more depth if you want to know what to expect from that stage.

How do you report a side effect or a suspect product?

If you experience a side effect you weren't expecting (or one that is more severe or prolonged than described here) you can report it directly to the MHRA through the Yellow Card reporting scheme. This matters more than it might seem: Mounjaro carries a Black Triangle (▼) in the UK because it is still under additional post-authorisation safety monitoring. Patient reports feed directly into that evidence base and can prompt regulatory action when a signal appears. You do not need a diagnosis to report; a suspicion is enough.

The Yellow Card scheme also accepts reports about suspect products, counterfeit or illegitimately sourced pens. If you'd like a fuller picture of what side effects to watch for if you're taking Mounjaro, that resource covers the warning signs worth keeping in mind when sourcing from any provider. Sourcing through a pharmacy you can verify on the GPhC register is the practical safeguard.

If you have questions about whether Mounjaro could be the right treatment for your weight loss goals, or how our prescribers approach the Mounjaro side effects conversation, speak to our prescribers through a free consultation, there's no obligation, and suitability is always assessed individually.